Risk factors for radiographic articular destruction of hands and wrists in rheumatoid arthritis

Journal of Rheumatology

Volumn 26, Issue 12, 1999, Pages 2534-2538

  Belghomari, Houari ^a   Saraux, Alain ^a   Allain, Jerome ^a   Guedes, Claudie ^a   Youinou, Pierre ^a   Le Goff, Paul ^a  

^a SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Hand; Radiograph; Rheumatoid arthritis

Indexed keywords

ANTINUCLEAR ANTIBODY; ANTIPERINUCLEAR FACTOR; C REACTIVE PROTEIN; HLA DR4 ANTIGEN; KERATIN ANTIBODY; RHEUMATOID FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HAND RADIOGRAPHY; HUMAN; JOINT DESTRUCTION; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; RISK FACTOR; WRIST RADIOGRAPHY;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; FEMALE; FINGER JOINT; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; WRIST JOINT;

EID: 0032726393     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Young A. Can we predict aggressive disease? Baillere's Clin Rheumatol 1997;11:27-48.
2. Scott DL, Symmons PM, Coulton BL, Popert AJ. Longterm outcome of treating rheumatoid arthritis: results after 20 years. Lancet 1987;1:1108-11.
3. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
4. Sharp JT, Young DY, Bluhm GB, et al. How many joints in the hand and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 1985;28:1326-35.
5. Youinou P, Le Goff P, Dumay A, Lelong A, Fauquert P, Jouquan J. The antiperinuclear factor. I. Clinical and serological associations. Clin Exp Rheumatol 1990;8:1-6.
6. Young BJ, Mallya RK, Leslie RDG, Clark CJ, Hamblin TJ. Antikeratin antibodies in rheumatoid arthritis. BMJ 1979;2:97-9.
7. Van der Heijde DMFM, van Leeuwen MA, van Riel PLCM, et al. Biannual radiographic assessments of hands and feet in a three-year prospective follow-up of patients with early rheumatoid arthritis. Arthritis Rheum 1992;35:26-34.
8. Plant MJ, Jones PW, Saklatvala J, Ollier WER, Dawes PT. Patterns of radiological progression in early rheumatoid arthritis: results of an 8 year prospective study. J Rheumatol 1998;25:417-26.
9. Sharp JT, Bluhm GB, Brook A, et al. Reproducibility of multiple observer scoring of radiologie abnormalities in the hands and wrists of patients with rheumatoid arthritis. Arthritis Rheum 1985; 28:16-24.
10. Cuchacovich M, Couret M, Peray P, Gatica H, Sany J. Precison of the Larsen and the Sharp methods of assessing radiologic change in patients with rheumatoid arthritis. Arthritis Rheum 1992;35:736-9.
11. Fex E, Jonsson K, Johnson V, Eberhardt K. Development of radiographic damage during the first 5-6 years of rheumatoid arthritis. Br J Rheumatol 1996;35:1106-15.
12. De Carvalho A, Graudal H, Jorgensen B. Evaluation of the progression of rheumatoid arthritis. Acta Radiol Diagn 1980;21:545-50.
13. Feigenbaum SL, Masi AT, Kaplan SB. Prognosis in rheumatoid arthritis. Am J Med 1979;66:377-83.
14. Stockman A, Emery P, Doyle T, Hopper J, Tait B, Muirden K. Relationship of progression of radiographic changes in hands and wrists, clinical features and HLA DR antigens in rheumatoid arthritis. J Rheumatol 1991;18:1001-7.
15. Van Schaardenburg, Hazes JMW, de Boer A, Zwinderman AH, Meijers KAE, Breedveld FC. Outcome of rheumatoid arthritis in relation to age and rheumatoid factor at diagnosis. J Rheumatol 1993;20:45-52.
16. Van der Heidje DMFM, van Riel PLM, Van Leeuwen MA, van't Hof MA, van Rijswijk MH, Van de Putte LBA. Older versus younger onset rheumatoid arthritis: results at onset and after two years of a prospective followup study of early rheumatoid arthritis. J Rheumatol 1991;18:1285-9.
17. Coste J, Spira A, Clerc D, Paolaggi JB. Prediction of articular destruction in rheumatoid arthritis: disease activity markers revisited. J Rheumatol 1997;24:28-34.
18. Deal CL, Meenan RF, Goldenberg DL, et al. The clinical features of elderly onset rheumatoid arthritis. Arthritis Rheum 1985; 28:987-93.
19. Terkeltaub R, Esdaile J, Decary F, Tannenbaum H. A clinical study of older age rheumatoid arthritis with comparison with a younger group. J Rheumatol 1983;10:418-24.
20. Van Zeben D, Hazes JMW, Zwinderman AH, et al. Association of HLA DR4 with a more progressive disease course in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:822-30.
21. Van Zeben D, Hazes JMW, Zwinderman AH, Vandenbrouke JP, Breedveld FC. Factors predicting the outcome of rheumatoid arthritis: results of a followup study. J Rheumatol 1993;20:1288-96.
22. Wordworth P, Pile KD, Duckely JD, et al. HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. Am J Hum Genet 1992;51:585-91.
23. Gough A, Faint J, Salmon M, et al. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 1994;37:1166-70.
24. Silman AJ, Reeback J, Jaraquemada D. HLA DR4 as a predictor of outcome 3 years after onset of rheumatoid arthritis. Rheumatol Int 1986;6:233-5.
25. Boki KA, Drosos A, Tzioufas AG, Lanchburry JS. Panayi GS, Moutsopoulos HM. Examination of HLA DR4 as a severity marker for rheumatoid arthritis in Greek patients. Ann Rheum Dis 1993;52:517-9.
26. Mottonen TT. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis 1988;47:648-53.
27. Paimela L, Palosuo T, Leirisalo-Repo M, Helve T, Aho K. Prognosis value of quantitative measurement of rheumatoid factor in early rheumatoid arthritis. Br J Rheumatol 1995;34:1146-50.
28. Weyand CM, Hicock KC, Conn DL, Goronzy JJ. The influence of HLA DRB1 gene on disease severity of rheumatoid arthritis. Ann Rheum Dis 1992;117:801-6.
29. MacGregor A, Ollier W, Thompson W, Jawaheer D, Silman A. HLA-DRB1 *0401/0404 genotype and rheumatoid arthritis: Increased association in men, young age at onset, and disease severity. J Rheumatol 1995;22:1032-6.
30. Moreno I, Valenzuela A, Garcia A, Yelamos J, Sanchez B, Hernanz W. Association of the shared epitope with radiological severity of rheumatoid arthritis. J Rheumatol 1996;23:6-9.
31. Perdriger A, Chales G, Semana G, et al. Role of the HLA DR and DQ association in the expression of extraarticular manifestations and rheumatoid factor in rheumatoid arthritis. J Rheumatol 1997;24:1272-6.
32. Kerstens PJS, Boerboms AMT, Jeurissen MEC, et al. Antiperinuclear factor and disease activity in rheumatoid arthritis: longitudinal evaluation during methotrexate and azathioprine therapy. J Rheumatol 1994;21:2190-4.
33. Paimela L, Gripenberg M, Kurki P, Leirisalo-Repo M. Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis. Ann Rheum Dis 1992;51:743-6.
34. Aho K, von Essen R, Kurki P, Palosuo T. Heliovaara M. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid arthritis process. J Rheumatol 1993;20:1278-81.
35. Manera C, Franceschini F, Cretti L, Braga S, Cattaneo R. Clinical heterogeneity of rheumatoid arthritis and the antiperinuclear factor. J Rheumatol 1994;21:2021-5.
36. Ordeig J, Guardia J. Diagnostic value of antikeratin antibodies in rheumatoid arthritis. J Rheumatol 1994;21:602-4.
37. Boki KA, Kurki P, Holtthofer H, Tzoufias AG, Drosos AA, Moutsopoulos HM. Prevalence of antikeratin antibodies in Greek patients with rheumatoid arthritis: a clinical, serologic, and immunogenetic study. J Rheumatol 1995;22:2046-8.